Immix Biopharma (Nasdaq: IMMX)
Head of Cell Therapy Technical Operations, Vice President
Immix Biopharma (Nasdaq: IMMX), Los Angeles, California, United States, 90079
Head of Cell Therapy Technical Operations, Vice PresidentHead of Cell Therapy Technical Operations, Vice President
Head of Cell Therapy Technical Operations, Vice President
Are you the right applicant for this opportunity Find out by reading through the role overview below. Our Values What You Will Do ·Own and provide technical guidance, strategic direction, and long-range planningin the execution of all CMC (Chemistry, Manufacturing and Controls) and related activities through BLA and commercial sales ·Lead cell therapy manufacturing, including all CMC functional areas – QA, QC, MSAT, GMP Manufacturing, Commercial Assay Validation ·Establish the requirements for the commercial manufacturing process, coordinating technical transfers to manufacturing and between sites, developing process qualification, process control, and comparability strategies, and supporting the authoring of technical sections of major regulatory documents. ·Contribute to strategic discussions for the overall Chemistry, Manufacturing, and Controls (CMC) and commercial strategy. ·Ongoing technical oversight of manufacturing, defining and driving a long-term process improvement lifecycle plan, and ensuring the successful execution of the technical strategy. ·Work cross-functionally across technical operations and closely with external Integrated Drug Manufacturing Organizations (IDMOs) ·Supervisory responsibilities for a technical team, driving technology transfer, validation, qualification, and comparability strategies while being recognized as a technical thought leader in cell therapy drug product manufacturing technology. ·Provide technical content for significant documents such as tech transfer plan/report, PPQ or comparability assessments, and author content for regulatory submissions. ·Own the technology transfer of the commercial assets including ownership of the tech transfer plan and final report. ·Develop product technical strategies including manufacturing requirements and process improvement plans as part of the technology transfer. ·Define the post-approval life cycle management plans and ensure successful and timely execution working across functional groups. ·Function as a subject matter expert for autologous T cell therapies and manufacturing technologies. ·Derive motivation from working in a small, entrepreneurial biotech environment, accepting the challenge of broad responsibilities and opportunities within a fast-paced, matrix-focused can-do culture. ·A “hands-on” operational approach and ability to deliver on corporate goals integrating internal and external, virtual resources lay at the core of this role. What We Look For ·Multi-year experience encompassing the above Who we are … Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a “digital filter” that filters out non-specific activation. NXC-201 is being evaluated in the U.S. multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a registrational design. Interim results were presented at ASCO 2025 in an oral presentation by Heather Landau, M.D. of Memorial Sloan Kettering Cancer Center. NXC-201 has been awarded Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA. Learn more at www.immixbio.com and www.BeProactiveInAL.com. Job Type: Full-time Schedule: ·Full time Experience: ·Pharma or CAR-T Language: Seniority level
Seniority levelExecutive Employment type
Employment typeFull-time IndustriesBiotechnology Referrals increase your chances of interviewing at Immix Biopharma (Nasdaq: IMMX) by 2x Sign in to set job alerts for “Head of Technical Operations” roles.Director of Technical Operations – (4x Onsite in NY/LA/NASH) – 4471 Los Angeles, CA $175,000.00-$205,000.00 2 weeks ago Rowland Heights, CA $124,000.00-$155,000.00 1 week ago IT Director (Co-working Space, Non-profit) Los Angeles, CA $115,400.00-$170,270.00 2 weeks ago Global Head of Advertising and Creative Operations Los Angeles, CA $160,000.00-$190,000.00 2 weeks ago Director Network-Data Center - 100% onsite Whittier, CA $166,940.00-$274,560.00 1 week ago Los Angeles, CA $300,000.00-$400,000.00 2 weeks ago Global Head of Policy Development - Trust and SafetyDirector of IT Business Development (SLED)Associate Director, Cloud and Hybrid Infrastructure Services / IS - Cloud & Hybrid Infrastructure Services / Full-time / Day ShiftAssociate Director, Global Business Svcs Tech Enablement StrategyDirector, Data Science - Personalization & Product AnalyticsVice President of Information Technologies and Systems Culver City, CA $196,995.00-$226,545.00 3 days ago Senior Director of Information TechnologyAssistant Vice President or Vice President, InfrastructureDirector, IT Transformation and Separation Los Angeles Metropolitan Area $207,000.00-$258,000.00 1 month ago We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
#J-18808-Ljbffr
Head of Cell Therapy Technical Operations, Vice President
Are you the right applicant for this opportunity Find out by reading through the role overview below. Our Values What You Will Do ·Own and provide technical guidance, strategic direction, and long-range planningin the execution of all CMC (Chemistry, Manufacturing and Controls) and related activities through BLA and commercial sales ·Lead cell therapy manufacturing, including all CMC functional areas – QA, QC, MSAT, GMP Manufacturing, Commercial Assay Validation ·Establish the requirements for the commercial manufacturing process, coordinating technical transfers to manufacturing and between sites, developing process qualification, process control, and comparability strategies, and supporting the authoring of technical sections of major regulatory documents. ·Contribute to strategic discussions for the overall Chemistry, Manufacturing, and Controls (CMC) and commercial strategy. ·Ongoing technical oversight of manufacturing, defining and driving a long-term process improvement lifecycle plan, and ensuring the successful execution of the technical strategy. ·Work cross-functionally across technical operations and closely with external Integrated Drug Manufacturing Organizations (IDMOs) ·Supervisory responsibilities for a technical team, driving technology transfer, validation, qualification, and comparability strategies while being recognized as a technical thought leader in cell therapy drug product manufacturing technology. ·Provide technical content for significant documents such as tech transfer plan/report, PPQ or comparability assessments, and author content for regulatory submissions. ·Own the technology transfer of the commercial assets including ownership of the tech transfer plan and final report. ·Develop product technical strategies including manufacturing requirements and process improvement plans as part of the technology transfer. ·Define the post-approval life cycle management plans and ensure successful and timely execution working across functional groups. ·Function as a subject matter expert for autologous T cell therapies and manufacturing technologies. ·Derive motivation from working in a small, entrepreneurial biotech environment, accepting the challenge of broad responsibilities and opportunities within a fast-paced, matrix-focused can-do culture. ·A “hands-on” operational approach and ability to deliver on corporate goals integrating internal and external, virtual resources lay at the core of this role. What We Look For ·Multi-year experience encompassing the above Who we are … Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a “digital filter” that filters out non-specific activation. NXC-201 is being evaluated in the U.S. multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a registrational design. Interim results were presented at ASCO 2025 in an oral presentation by Heather Landau, M.D. of Memorial Sloan Kettering Cancer Center. NXC-201 has been awarded Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA. Learn more at www.immixbio.com and www.BeProactiveInAL.com. Job Type: Full-time Schedule: ·Full time Experience: ·Pharma or CAR-T Language: Seniority level
Seniority levelExecutive Employment type
Employment typeFull-time IndustriesBiotechnology Referrals increase your chances of interviewing at Immix Biopharma (Nasdaq: IMMX) by 2x Sign in to set job alerts for “Head of Technical Operations” roles.Director of Technical Operations – (4x Onsite in NY/LA/NASH) – 4471 Los Angeles, CA $175,000.00-$205,000.00 2 weeks ago Rowland Heights, CA $124,000.00-$155,000.00 1 week ago IT Director (Co-working Space, Non-profit) Los Angeles, CA $115,400.00-$170,270.00 2 weeks ago Global Head of Advertising and Creative Operations Los Angeles, CA $160,000.00-$190,000.00 2 weeks ago Director Network-Data Center - 100% onsite Whittier, CA $166,940.00-$274,560.00 1 week ago Los Angeles, CA $300,000.00-$400,000.00 2 weeks ago Global Head of Policy Development - Trust and SafetyDirector of IT Business Development (SLED)Associate Director, Cloud and Hybrid Infrastructure Services / IS - Cloud & Hybrid Infrastructure Services / Full-time / Day ShiftAssociate Director, Global Business Svcs Tech Enablement StrategyDirector, Data Science - Personalization & Product AnalyticsVice President of Information Technologies and Systems Culver City, CA $196,995.00-$226,545.00 3 days ago Senior Director of Information TechnologyAssistant Vice President or Vice President, InfrastructureDirector, IT Transformation and Separation Los Angeles Metropolitan Area $207,000.00-$258,000.00 1 month ago We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
#J-18808-Ljbffr